N-Nitroso-Pramipexole
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist that works on the nervous system to help treat the symptoms of Parkinson disease. Pramipexole is also used to treat Restless Legs Syndrome (RLS). N-Nitroso-Pramipexole is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso-Pramipexole chemically represented as (S)-N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-propylnitrous amide .Synchemia is the leading manufacturing and exporter of N-Nitroso-Pramipexole . We supply N-Nitroso-Pramipexole with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014935 |
| CAS No | NA |
| Mol.F. | C16H22N4O3S |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014936 |
| CAS No | NA |
| Mol.F. | C30H40N6O3S |
| Mol.Wt. | 564.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014937 |
| CAS No | NA |
| Mol.F. | C30H40N6O3S |
| Mol.Wt. | 564.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014938 |
| CAS No | NA |
| Mol.F. | C30H39N7O4S |
| Mol.Wt. | 593.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014939 |
| CAS No | NA |
| Mol.F. | C19H28N4O3S |
| Mol.Wt. | 392.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014940 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014941 |
| CAS No | NA |
| Mol.F. | C11H16N4O3S |
| Mol.Wt. | 284.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014942 |
| CAS No | NA |
| Mol.F. | C17H24N4O3S |
| Mol.Wt. | 364.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N014943 |
| CAS No | NA |
| Mol.F. | C16H21N5O4S |
| Mol.Wt. | 379.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014944 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014945 |
| CAS No | NA |
| Mol.F. | C17H24N4O4S |
| Mol.Wt. | 380.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014946 |
| CAS No | NA |
| Mol.F. | C45H40N6O3 |
| Mol.Wt. | 712.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014947 |
| CAS No | NA |
| Mol.F. | C39H36N6O3 |
| Mol.Wt. | 636.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014948 |
| CAS No | NA |
| Mol.F. | C20H21N3O3 |
| Mol.Wt. | 351.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014949 |
| CAS No | NA |
| Mol.F. | C24H28N6O4 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014950 |
| CAS No | NA |
| Mol.F. | C24H28N6O4 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |